Cargando…
IgA nephropathy following COVID-19 vaccination: challenges and perspectives
Autores principales: | Niel, Olivier, de la Fuente Garcia, Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963394/ https://www.ncbi.nlm.nih.gov/pubmed/35352190 http://dx.doi.org/10.1007/s00467-022-05476-7 |
Ejemplares similares
-
IgA nephropathy presenting as rapidly progressive glomerulonephritis following first dose of COVID-19 vaccine
por: Niel, Olivier, et al.
Publicado: (2021) -
Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis
por: Zan, Jincan, et al.
Publicado: (2022) -
Histologic correlates of gross hematuria following Moderna COVID-19 vaccine in patients with IgA nephropathy
por: Kudose, Satoru, et al.
Publicado: (2021) -
Macroscopic hematuria in two children with IgA nephropathy remission following Pfizer COVID-19 vaccination
por: Udagawa, Tomohiro, et al.
Publicado: (2022) -
IgA nephropathy in IgG kappa multiple myeloma
por: Couto, Maria Eduarda, et al.
Publicado: (2021)